We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

14 hedge funds and large institutions have $7.21M invested in Tenax Therapeutics in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

15% more capital invested

Capital invested by funds: $6.28M → $7.21M (+$932K)

0% less ownership

Funds ownership: 0.02% → 0.02% (-0%)

13% less funds holding

Funds holding: 16 → 14 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$714K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$278K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$136K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$42.8K
5
VFA
Valeo Financial Advisors
Indiana
+$10.7K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$73K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$41K
3
TRCT
Tower Research Capital (TRC)
New York
-$39.3K
4
Citadel Advisors
Citadel Advisors
Florida
-$25K
5
TSS
Two Sigma Securities
New York
-$24K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$3.84M – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$1.42M +$714K +200 +75%
BlackRock
3
BlackRock
New York
$1.14M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$338K +$278K +78 +236%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$115K +$136K +38 New
FWP
6
FAS Wealth Partners
Kansas
$111K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$99K +$42.8K +12 +57%
Ameriprise
8
Ameriprise
Minnesota
$57K – – –
Northern Trust
9
Northern Trust
Illinois
$32K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$30K -$25K -7 -41%
William Blair & Company
11
William Blair & Company
Illinois
$19K – – –
VFA
12
Valeo Financial Advisors
Indiana
$10K +$10.7K +3 New
UBS Group
13
UBS Group
Switzerland
$2K -$17.8K -5 -83%
BCV
14
Banque Cantonale Vaudoise
Switzerland
$2K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$1K -$39.3K -11 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
– -$73K -25 Closed
Two Sigma Advisers
17
Two Sigma Advisers
New York
– -$41K -14 Closed
TSS
18
Two Sigma Securities
New York
– -$24K -8 Closed

TENX Hedge Fund Activity: Q1 2021 in Review

14 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2021, worth a combined $7.21M — up 15% from $6.28M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TENX and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $714K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $73K sold.

  • 14 institutional investors held Tenax Therapeutics (TENX) as of Q1 2021, down from 16 in Q4 2020.
  • Funds reported $7.21M of Tenax Therapeutics stock for Q1 2021, up 15% quarter-over-quarter.
  • 2 funds opened new Tenax Therapeutics positions in Q1 2021 and 4 closed out, a net change of -2 holders.
  • The largest Tenax Therapeutics buyer in Q1 2021 was Renaissance Technologies, an estimated $714K added.
  • The largest Tenax Therapeutics seller in Q1 2021 was Two Sigma Investments, an estimated $73K sold.

Based on aggregated 13F filings for Q1 2021.